A Promising Tool in Heart Health Maintenance & Recovery
- Tyler Briscoe
- Feb 9, 2022
- 2 min read
Updated: Aug 19
Heart disease is the leading cause of death in the United States, with one in every four deaths attributed to cardiac issues. About 805,000 people die of heart attacks in the US every year, with 200,000 occurring in people who had previously experienced a heart attack.
Traditional cardiovascular care often involves risky invasive procedures and a dependency on pharmaceuticals. Current care following a heart attack focuses on stabilizing the patient, but long-term consequences of poor tissue healing and subsequent impaired heart function significantly decreases future quality of life.
Mesenchymal Stem Cells (MSCs), the body's natural healing cells, have been shown to aid in maintaining heart health and providing marked improvements in heart attack recovery when used quickly following a heart attack.
MSCs can emit a secretome that assists the body in recovery following a heart attack by decreasing the inflammatory cytokine response as well as creating new blood vessels, limiting scar tissue, and triggering other regenerative cells near the damaged area to mature and begin to function.
In this webinar, we dive into the attributes of MSCs and discuss the notable cardiovascular benefits that MSCs have exhibited in clinical studies. We address how Celltex differs from other stem cell companies, most notably in our culturing of one’s own cells and stringent quality processes for the safest and best possible results.
Dr. Richard Taylor, Celltex client and retired physician, joins to share his unique journey in finding solutions for his life-threatening aortic dissection.
ABOUT THE GUEST:
Richard Taylor, MD
Retired Physician & Celltex Client
As a retired physician, Dr. Richard Taylor would use every tool he could to keep patients healthy. But when he was faced with type A aortic dissection in 2016, it was his health that was compromised. Doctors presented him with the option of a surgical procedure that could result in death or serious complications. Unwilling to accept this risk, Dr. Taylor looked into every other option possible until he landed on stem cell therapy.
At the end of 2016, Dr. Taylor reached out to Celltex in an attempt to avoid the incredibly invasive surgery. Although his stem cells didn't fix the aortic dissection, Dr. Taylor believes they played a unique role in the events that likely saved his life.
